Topline
Supreme Court justices suggested Tuesday they’re unlikely to roll back federal approvals of abortion drug mifepristone, with even conservative justices expressing skepticism that the anti-abortion rights advocates who brought a case challenging the drug’s legality have standing to sue as the court heard its most consequential abortion case since it overturned Roe v. Wade in 2022.
Continue Reading
News Source: www.forbes.com